Please Wait a Moment
X

CTS History

01Dec

Babesia

SuperUser Account |01 Dec, 2015 | Return|

In October, due to demand from existing healthcare partners, CTS began testing blood donors for antibody to Babesia microti under an Investigational New Drug exemption as a release test.

About the Author

Related

Source Plasma / Blood Donor Testing

Source Plasma / Blood Donor Testing

In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).

Read More >
Dengue Testing

Dengue Testing

CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.

Read More >
On-time test results

On-time test results

Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...

Read More >

Operational Excellence

CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...

Read More >
Implementation of a COVID-19 Test

Implementation of a COVID-19 Test

CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROS® testing platform to perform COVID-1...

Read More >
CTS merges with the three Red Cross testing laboratories

CTS merges with the three Red Cross testing laboratories

CTS merges with the three Red Cross testing laboratories located in Charlotte, Portland and St. Loui...

Read More >